{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T16:40:17Z","timestamp":1782837617430,"version":"3.54.5"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10072-022-06144-2","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T23:02:47Z","timestamp":1653087767000},"page":"5099-5101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2"],"prefix":"10.1007","volume":"43","author":[{"given":"Cristina","family":"Gonz\u00e1lez-Mingot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"L\u00f3pez-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Brieva-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"6144_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.nurt.2007.01.014","volume":"4","author":"M Strupp","year":"2007","unstructured":"Strupp M, Zwergal A, Brandt T (2007) Episodic ataxia type 2. Neurotherapeutics 4:267\u2013273","journal-title":"Neurotherapeutics"},{"key":"6144_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ana.410410105","volume":"41","author":"RW Baloh","year":"1997","unstructured":"Baloh RW, Yue Q, Furman JM, Nelson SF (1997) Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p. Ann Neurol 41:8\u201316","journal-title":"Ann Neurol"},{"key":"6144_CR3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s00415-004-0299-1","volume":"251","author":"H Harno","year":"2004","unstructured":"Harno H, Hirvonen T, Kaunisto MA et al (2004) Acetazolamide improves neurological abnormalities in a family with episodic ataxia type 2 (EA-2). J Neurol 251:232","journal-title":"J Neurol"},{"issue":"10","key":"6144_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1212\/WNL.0000000000005055","volume":"90","author":"TA Zesiewicz","year":"2018","unstructured":"Zesiewicz TA, Wilmot G, Kuo SH, Perlman S, Greenstein PE, Ying SH, Ashizawa T, Subramony SH, Schmahmann JD, Figueroa KP et al (2018) Comprehensive systematic review summary: treatment of cerebellar motor dysfunction and ataxia: report of the guideline development, dissemination, and implementation subcommittee of the American academy of neurology. Neurology 90(10):464\u2013471","journal-title":"Neurology"},{"issue":"7","key":"6144_CR5","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1111\/ene.13327","volume":"24","author":"H Lee","year":"2017","unstructured":"Lee H, Jang D-H, Jang J-H, Kim T (2017) Effectiveness of levetiracetam in an acetazolamide-unresponsive patient with episodic ataxia type 2 by a novel CACNA1A nonsense mutation. Eur J Neurol 24(7):e43\u2013e44. https:\/\/doi.org\/10.1111\/ene.13327","journal-title":"Eur J Neurol"},{"issue":"9","key":"6144_CR6","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1007\/s10072-021-05368-y","volume":"42","author":"S Na","year":"2021","unstructured":"Na S, Kim T (2021) Efficacy of levetiracetam in patients with episodic ataxia type 2 caused by CACNA1A mutation: three case reports. Neurol Sci 42(9):3897\u20133899. https:\/\/doi.org\/10.1007\/s10072-021-05368-y","journal-title":"Neurol Sci"},{"issue":"4","key":"6144_CR7","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00415-020-09717-3","volume":"267","author":"J Gandini","year":"2020","unstructured":"Gandini J, Manto M, Bremova-Ertl T, Feil K, Strupp M (2020) The neurological update: therapies for cerebellar ataxias in 2020. J Neurol 267(4):1211\u20131220. https:\/\/doi.org\/10.1007\/s00415-020-09717-3","journal-title":"J Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06144-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-06144-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06144-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T13:17:42Z","timestamp":1659532662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-06144-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":7,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["6144"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-06144-2","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]},"assertion":[{"value":"11 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval statement is not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients accepted and signed the informed consent for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}